Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    Home»Food/Beverage»Innovation Beverage Group Limited Announces Pricing of $5.4 Million Initial Public Offering on the Nasdaq Capital Market Under Symbol “IBG”
    Food/Beverage

    Innovation Beverage Group Limited Announces Pricing of $5.4 Million Initial Public Offering on the Nasdaq Capital Market Under Symbol “IBG”

    Marie JonesBy Marie JonesSeptember 26, 2024No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Innovation Beverage Group Limited (IBG or the Company), a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands with a focus on premium and super premium brands, today announced the pricing of its initial public offering (the Offering) of 1,350,000 ordinary shares, at a public offering price of $4.00 per share for total gross proceeds to the Company of $5.4 million, before deducting underwriting discounts and offering expenses. In addition, the Company has granted a 30-day option to the underwriters to purchase up to an additional 202,500 ordinary shares solely to cover over-allotments, if any.

    The ordinary shares are expected to begin trading on The Nasdaq Capital Market, under the symbols “IBG”, on September 26, 2024. The Offering is expected to close on or about September 27, 2024, subject to satisfaction of customary closing conditions.

    The Benchmark Company, LLC is acting as sole book-running manager for the Offering. Sichenzia Ross Ference Carmel LLP is serving as legal counsel to the Company.

    A registration statement on Form F-1 (No. 333-266965) relating to the securities being sold in this offering was declared effective by the Securities and Exchange Commission (the “SEC”) on September 25, 2024. The Offering is being made only by means of a prospectus. Copies of the final prospectus may be obtained, when available, on the SEC’s website, www.sec.gov, or by contacting The Benchmark Company, LLC, 150 East 58th Street, #17, New York, New York 10155, at (212) 312-6700.

    This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    About Innovation Beverage Group Limited
    Innovation Beverage Group Limited is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands with a focus on premium and super premium brands. The Company owns exclusive manufacturing rights in its beverage portfolio. The Company’s products are sold in both the United States and Australian markets. To learn more, go to https://www.innovationbev.com/.

    Safe Harbor Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “may”, “could”, “expects”, “projects,” “intends”, “plans”, “believes”, “predicts”, “anticipates”, “hopes”, “estimates” and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks and are based upon several assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the Company’s control. Actual results (including the anticipated benefits of the offering described herein) may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the risk factors described in the Company’s filings with the Securities and Exchange Commission. The forward-looking statements are applicable only as of the date on which they are made, and the Company does not assume any obligation to update any forward-looking statements.

    Investor Relations Contact:
    TraDigital IR
    John McNamara
    917-658-2602
    John@tradigitalir.com

    SOURCE: Innovation Beverage Group

    Innovation Beverage Group
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleU.S. Polo Assn. Concludes the Successful European Polo Season
    Next Article HeartCore’s Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange

    Related Posts

    SAPPE Showcases Product Innovations at SIAL Paris 2026

    October 20, 2026

    CropLife Asia Welcomes New BASF, Corteva and FMC Representatives to Board

    October 20, 2026

    ComplianceQuest and Zolon PCS Selected to Modernize U.S. Food and Drug Administration (FDA) Enterprise Quality Management System

    October 7, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Latest News

    • GA-ASI Partnering With Spirit Defense For FQ-42 CCA Production
    • Study Finds Lower Rates of Overweight Among Vegan-Fed Cats
    • Savills Hong Kong Hosts Grand Reception to Celebrate 40th Anniversary, Over 300 Guests Gather to Mark Glorious Milestone
    • ASN 2026: HighTide Therapeutics Presents New HTD1801 Data Highlighting Therapeutic Potential in Chronic Kidney Disease
    • MicroVision Begins Commercial Production of MOVIA(TM) Pro for Superior Short-Range Sensing and Onboard Perception, Enabling Physical AI at the Edge
    • New Global Initiative Seeks to Modernize Health Workforce Mobility
    • P&G, Nestle, Mars, AstraZeneca, ITC and Bekaert win OMP Supply Chain Awards
    • Zhipu, Jiangmen, QuantGroup and Other Investors Join Forces to Back RMB 1 Billion Cognitive Intelligence Venture Capital Fund for Physical AI Ecosystem Development
    • Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
    • Chervon Appoints Stephen Sarnocinski to President – End User Research, Sales and Service – OPE Commercial Landscaping Market Global
    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.